{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:26:13Z","timestamp":1794072373323,"version":"4.8.0"},"reference-count":54,"publisher":"American Association for Laboratory Animal Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:p>\n                    Extended-release buprenorphine formulations are commonly used to control postoperative pain in rodents with minimal handling-related stress. An FDA-indexed formulation is now available that has been demonstrated safe and effective with ketamine-xylazine and isoflurane anesthesia; however, safe use in combination with tribromoethanol, a nonpharmaceutical-grade anesthetic sometimes favored for short, high-volume procedures, has not been reported. Effects on pregnancy and offspring have also not been examined. In this study we compared the safety and efficacy of the FDA-indexed formulation at the labeled dose (3.25 mg\/kg) to the compounded extended-release buprenorphine formulation used by the centralized Transgenic Core at our institution at the manufacturer-recommended dosage (1 mg\/kg) in CD-1 mice under tribromoethanol anesthesia. A pilot (\n                    <jats:italic>n<\/jats:italic>\n                    = 5 females per drug) was initially conducted with anesthetic and analgesic in the absence of surgical manipulation, after which the formulations were compared in embryo transfer and vasectomy surgeries (\n                    <jats:italic>n<\/jats:italic>\n                    = 10 males or females per drug). Relative efficacy was assessed at 6, 24, 48, and 72 h after surgery using a cageside ethogram, frequency of rearing behavior compared with baseline, and weight change. No differences were seen between analgesic treatment groups. Safety was evaluated by intraoperative respiratory rate, recovery time, incidence of analgesic injection site lesions, and gross necropsy. Ulceration was only observed at the injection site of mice receiving compounded drug; no other differences between treatments were observed. Effects on pregnancy were evaluated by comparing pregnancy success, litter size, and pup weight at weaning between treatment groups in the initial experiment and embryo transfers subsequently performed by the Transgenic Core (\n                    <jats:italic>n<\/jats:italic>\n                    = 19 sets). No significant differences were identified. These results indicate that both formulations can be safely used in vasectomy and embryo transfer surgeries under tribromoethanol anesthesia; however, the FDA-indexed product may improve welfare by decreasing injection site ulceration compared with the compounded formulation.\n                  <\/jats:p>","DOI":"10.30802\/aalas-jaalas-24-161","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T20:01:39Z","timestamp":1750276899000},"page":"696-705","source":"Crossref","is-referenced-by-count":2,"title":["Comparative Safety and Efficacy of Extended-Release Buprenorphine Formulations for Mouse Reproductive Surgeries under Tribromoethanol"],"prefix":"10.30802","volume":"64","author":[{"given":"Sarah R","family":"Gillis-Smith","sequence":"first","affiliation":[{"name":"Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmer","family":"Umana","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony E","family":"Chavarria","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niora J","family":"Fabian","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E","family":"Erdman","sequence":"additional","affiliation":[{"name":"Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"12258","reference":[{"key":"bib1","series-title":"Guide for the Care and Use of Laboratory Animals.","year":"2011","unstructured":"Institute for Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals. 8th ed. National Academies Press; 2011."},{"issue":"5","key":"bib2","series-title":"J Am Assoc Lab Anim Sci.","first-page":"448","article-title":"Efficacy of 3 buprenorphine formulations for the attenuation of hypersensitivity after plantar incision in immunodeficient NSG mice","volume":"61","author":"Arthur JD","year":"2022","unstructured":"Arthur JD, Alamaw ED, Jampachairsri K, et al. Efficacy of 3 buprenorphine formulations for the attenuation of hypersensitivity after plantar incision in immunodeficient NSG mice. J Am Assoc Lab Anim Sci. 2022;61(5):448\u2013456."},{"issue":"4","key":"bib3","series-title":"J Am Assoc Lab Anim Sci.","first-page":"381","article-title":"Assessment of the safety and efficacy of pre-emptive use of extended-release buprenorphine for mouse laparotomy","volume":"61","author":"Chan G","year":"2022","unstructured":"Chan G, Si C, Nichols MR, Kennedy L. Assessment of the safety and efficacy of pre-emptive use of extended-release buprenorphine for mouse laparotomy. J Am Assoc Lab Anim Sci. 2022;61(4):381\u2013387."},{"issue":"6","key":"bib4","series-title":"Comp Med.","first-page":"468","article-title":"Clinical management of pain in rodents","volume":"69","author":"Foley PL","year":"2019","unstructured":"Foley PL, Kendall LV, Turner PV. Clinical management of pain in rodents. Comp Med. 2019;69(6):468\u2013489."},{"issue":"6","key":"bib5","series-title":"J Am Assoc Lab Anim Sci.","first-page":"531","article-title":"Comparing three formulations of buprenorphine in an incisional pain model in mice","volume":"62","author":"Lopez-Echeverria G","year":"2023","unstructured":"Lopez-Echeverria G, Alamaw E, Gorman G, Jampachaisri K, Huss MK, Pacharinsak C. Comparing three formulations of buprenorphine in an incisional pain model in mice. J Am Assoc Lab Anim Sci. 2023;62(6):531\u2013537."},{"issue":"5","key":"bib6","series-title":"J Am Assoc Lab Anim Sci.","first-page":"468","article-title":"Pharmacokinetics of sustained-release and extended-release buprenorphine in mice after surgical catheterization","volume":"61","author":"Saenz M","year":"2022","unstructured":"Saenz M, Bloom-Saldana EA, Synold T, Ermel RW, Fueger PT, Finlay JB. Pharmacokinetics of sustained-release and extended-release buprenorphine in mice after surgical catheterization. J Am Assoc Lab Anim Sci. 2022;61(5):468\u2013474."},{"key":"bib7","article-title":"CVM GFI #256\u2014compounding animal drugs from bulk drug substances","year":"2022","unstructured":"FDA, Center for Veterinary Medicine. CVM GFI #256\u2014compounding animal drugs from bulk drug substances. August 10, 2022. Accessed November 15, 2024. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/cvm-gfi-256-compounding-animal-drugs-bulk-drug-substances."},{"key":"bib8","article-title":"Bulk drug substances reviewed and not listed","year":"2024","unstructured":"FDA, Center for Veterinary Medicine. Bulk drug substances reviewed and not listed. November 26, 2024. Accessed March 5, 2025. https:\/\/www.fda.gov\/animal-veterinary\/animal-drug-compounding\/bulk-drug-substances-reviewed-and-not-listed."},{"issue":"2","key":"bib9","series-title":"Animal Model Exp Med.","first-page":"129","article-title":"Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post-operative hypersensitivity in an incisional pain model in mice (Mus musculus)","volume":"4","author":"Navarro K","year":"2021","unstructured":"Navarro K, Jampachaisri K, Huss M, Pacharinsak C. Lipid bound extended release buprenorphine (high and low doses) and sustained release buprenorphine effectively attenuate post-operative hypersensitivity in an incisional pain model in mice (Mus musculus). Animal Model Exp Med. 2021;4(2):129\u2013137."},{"issue":"1","key":"bib10","series-title":"Int J Pharma Res Health Sci.","first-page":"2169","article-title":"Buprenorphine analgesia in mice","volume":"6","author":"Itzoe M","year":"2018","unstructured":"Itzoe M, Ye X, Sarabia-Estrada R, DeTolla L, Tyler BM, Guarnieri M. Buprenorphine analgesia in mice. Int J Pharma Res Health Sci. 2018;6(1):2169\u20132177."},{"issue":"1","key":"bib11","series-title":"J Pharm Bioallied Sci.","first-page":"43","article-title":"Thermal latency studies in opiate-treated mice","volume":"6","author":"Schildhaus N","year":"2014","unstructured":"Schildhaus N, Trink E, Polson C, et al. Thermal latency studies in opiate-treated mice. J Pharm Bioallied Sci. 2014;6(1):43\u201347."},{"issue":"2","key":"bib12","series-title":"Lab Anim.","first-page":"100","article-title":"Safety studies of post-surgical buprenorphine therapy for mice","volume":"49","author":"Traul KA","year":"2015","unstructured":"Traul KA, Romero JB, Brayton C, et al. Safety studies of post-surgical buprenorphine therapy for mice. Lab Anim. 2015;49(2):100\u2013110."},{"issue":"5","key":"bib13","series-title":"J Am Assoc Lab Anim Sci.","first-page":"416","article-title":"Comparison of systemic extended-release buprenorphine and local extended-release bupivacaine-meloxicam as analgesics for laparotomy in mice","volume":"62","author":"Yang P","year":"2023","unstructured":"Yang P, Hish G, Lester PA. Comparison of systemic extended-release buprenorphine and local extended-release bupivacaine-meloxicam as analgesics for laparotomy in mice. J Am Assoc Lab Anim Sci. 2023;62(5):416\u2013422."},{"issue":"2","key":"bib14","series-title":"J Am Assoc Lab Anim Sci.","first-page":"147","article-title":"Comparative pharmacokinetics and injection site histopathology in nude mice treated with long-acting buprenorphine formulations","volume":"62","author":"Illario JA","year":"2023","unstructured":"Illario JA, Osborn KG, Garcia AV, et al. Comparative pharmacokinetics and injection site histopathology in nude mice treated with long-acting buprenorphine formulations. J Am Assoc Lab Anim Sci. 2023;62(2):147\u2013152."},{"issue":"2","key":"bib15","series-title":"Pain.","first-page":"358","article-title":"Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences","volume":"160","author":"Rosen SF","year":"2019","unstructured":"Rosen SF, Ham B, Haichin M, et al. Increased pain sensitivity and decreased opioid analgesia in T-cell-deficient mice and implications for sex differences. Pain. 2019;160(2):358\u2013366."},{"key":"bib16","article-title":"Ethiqa XR efficacy and safety","year":"2024","unstructured":"Fidelis Animal Health. Ethiqa XR efficacy and safety. June 5, 2024. Accessed March 5, 2025. https:\/\/ethiqaxr.com\/efficacy-safety\/."},{"issue":"6","key":"bib17","series-title":"J Am Assoc Lab Anim Sci.","first-page":"815","article-title":"Duration of action of sustained-release buprenorphine in 2 strains of mice","volume":"51","author":"Carbone ET","year":"2012","unstructured":"Carbone ET, Lindstrom KE, Diep S, Carbone L. Duration of action of sustained-release buprenorphine in 2 strains of mice. J Am Assoc Lab Anim Sci. 2012;51(6):815\u2013819."},{"issue":"2","key":"bib18","series-title":"J Am Assoc Lab Anim Sci.","first-page":"160","article-title":"Pharmacokinetic profiles of meloxicam and sustained-release buprenorphine in prairie dogs (Cynomys ludovicianus)","volume":"56","author":"Cary CD","year":"2017","unstructured":"Cary CD, Lukovsky-Akhsanov NL, Gallardo-Romero NF, et al. Pharmacokinetic profiles of meloxicam and sustained-release buprenorphine in prairie dogs (Cynomys ludovicianus). J Am Assoc Lab Anim Sci. 2017;56(2):160\u2013165."},{"issue":"4","key":"bib19","series-title":"J Am Assoc Lab Anim Sci.","first-page":"387","article-title":"Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice","volume":"53","author":"Clark TS","year":"2014","unstructured":"Clark TS, Clark DD, Hoyt RF. Pharmacokinetic comparison of sustained-release and standard buprenorphine in mice. J Am Assoc Lab Anim Sci. 2014;53(4):387\u2013391."},{"issue":"1","key":"bib20","series-title":"Sci Rep.","first-page":"11864","article-title":"Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus)","volume":"13","author":"Fabian NJ","year":"2023","unstructured":"Fabian NJ, Mannion AJ, Jamiel M, et al. Evaluation and comparison of pharmacokinetic profiles and safety of two extended-release buprenorphine formulations in common marmosets (Callithrix jacchus). Sci Rep. 2023;13(1):11864."},{"issue":"3","key":"bib21","series-title":"J Am Assoc Lab Anim Sci.","first-page":"329","article-title":"Predictors of subcutaneous injection site reactions to sustained-release buprenorphine in rhesus macaques (Macaca mulatta)","volume":"60","author":"Haertel AJ","year":"2021","unstructured":"Haertel AJ, Schultz MA, Colgin LM, Johnson AL. Predictors of subcutaneous injection site reactions to sustained-release buprenorphine in rhesus macaques (Macaca mulatta). J Am Assoc Lab Anim Sci. 2021;60(3):329\u2013336."},{"issue":"1","key":"bib22","series-title":"J Zoo Wildl Med.","first-page":"52","article-title":"Pharmacokinetics of a single subcutaneous dose of sustained release buprenorphine in northern elephant seals (Mirounga angustirostris)","volume":"46","author":"Molter CM","year":"2015","unstructured":"Molter CM, Barbosa L, Johnson S, Knych HK, Chinnadurai SK, Wack RF. Pharmacokinetics of a single subcutaneous dose of sustained release buprenorphine in northern elephant seals (Mirounga angustirostris). J Zoo Wildl Med. 2015;46(1):52\u201361."},{"issue":"5","key":"bib23","series-title":"J Am Assoc Lab Anim Sci.","first-page":"494","article-title":"Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy","volume":"53","author":"Nunamaker EA","year":"2014","unstructured":"Nunamaker EA, Stolarik DF, Ma J, Wilsey AS, Jenkins GJ, Medina CL. Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy. J Am Assoc Lab Anim Sci. 2014;53(5):494\u2013501."},{"issue":"6","key":"bib24","series-title":"J Am Assoc Lab Anim Sci.","first-page":"789","article-title":"Pharmacokinetics and paw withdrawal pressure in female guinea pigs (Cavia porcellus) treated with sustained-release buprenorphine and buprenorphine hydrochloride","volume":"55","author":"Smith BJ","year":"2016","unstructured":"Smith BJ, Wegenast DJ, Hansen RJ, Hess AM, Kendall LV. Pharmacokinetics and paw withdrawal pressure in female guinea pigs (Cavia porcellus) treated with sustained-release buprenorphine and buprenorphine hydrochloride. J Am Assoc Lab Anim Sci. 2016;55(6):789\u2013793."},{"issue":"6","key":"bib25","series-title":"J Am Assoc Lab Anim Sci.","first-page":"692","article-title":"Pharmacokinetics of sustained-release and transdermal buprenorphine in G\u00f6ttingen minipigs (Sus scrofa domestica)","volume":"53","author":"Thiede AJ","year":"2014","unstructured":"Thiede AJ, Garcia KD, Stolarik DF, Ma J, Jenkins GJ, Nunamaker EA. Pharmacokinetics of sustained-release and transdermal buprenorphine in G\u00f6ttingen minipigs (Sus scrofa domestica). J Am Assoc Lab Anim Sci. 2014;53(6):692\u2013699."},{"issue":"1","key":"bib26","series-title":"J Am Assoc Lab Anim Sci.","first-page":"67","article-title":"Pharmacokinetic profiles of a new extended-release buprenorphine formulation in cynomolgus macaques (Macaca fascicularis)","volume":"63","author":"Castillo-Pratts DID","year":"2024","unstructured":"Castillo-Pratts DID, Rosenfeld C, Kirschner S, Nunamaker E, Reim D, Bauer C. Pharmacokinetic profiles of a new extended-release buprenorphine formulation in cynomolgus macaques (Macaca fascicularis). J Am Assoc Lab Anim Sci. 2024;63(1):67\u201373."},{"issue":"1","key":"bib27","series-title":"J Am Assoc Lab Anim Sci.","first-page":"81","article-title":"Extended-release buprenorphine, an FDA-indexed analgesic, attenuates mechanical hypersensitivity in rats (Rattus norvegicus)","volume":"61","author":"Alamaw ED","year":"2022","unstructured":"Alamaw ED, Franco BD, Jampachaisri K, Huss MK, Pacharinsak C. Extended-release buprenorphine, an FDA-indexed analgesic, attenuates mechanical hypersensitivity in rats (Rattus norvegicus). J Am Assoc Lab Anim Sci. 2022;61(1):81\u201388."},{"key":"bib28","series-title":"Front Neuroendocrinol.","first-page":"1","article-title":"Modeling prenatal opioid exposure in animals: current findings and future directions","volume":"51","author":"Byrnes EM","year":"2018","unstructured":"Byrnes EM, Vassoler FM. Modeling prenatal opioid exposure in animals: current findings and future directions. Front Neuroendocrinol. 2018;51:1\u201313."},{"issue":"5","key":"bib29","series-title":"Trends Neurosci.","first-page":"367","article-title":"Advances in animal models of prenatal opioid exposure","volume":"47","author":"Ferrante JR","year":"2024","unstructured":"Ferrante JR, Blendy JA. Advances in animal models of prenatal opioid exposure. Trends Neurosci. 2024;47(5):367\u2013382."},{"issue":"1","key":"bib30","series-title":"Biol Reprod.","first-page":"4","article-title":"Preimplantation mouse embryo is a target for opioid ligand-receptor signaling","volume":"91","author":"Chen Y","year":"2014","unstructured":"Chen Y, Kong S, Tang X, et al. Preimplantation mouse embryo is a target for opioid ligand-receptor signaling. Biol Reprod. 2014;91(1):4."},{"issue":"9","key":"bib31","series-title":"Mol Reprod Dev.","first-page":"1236","article-title":"Implication of mu opioid receptor in the in vitro maturation of oocytes and its effects on subsequent fertilization and embryo development in mice","volume":"86","author":"Olabarrieta E","year":"2019","unstructured":"Olabarrieta E, Totorikaguena L, Agirregoitia N, Agirregoitia E. Implication of mu opioid receptor in the in vitro maturation of oocytes and its effects on subsequent fertilization and embryo development in mice. Mol Reprod Dev. 2019;86(9):1236\u20131244."},{"issue":"5","key":"bib32","series-title":"Biol Reprod.","first-page":"118","article-title":"Systemic morphine treatment derails normal uterine receptivity, leading to embryo implantation failure in mice","volume":"92","author":"Tang X","year":"2015","unstructured":"Tang X, Chen Y, Ran H, et al. Systemic morphine treatment derails normal uterine receptivity, leading to embryo implantation failure in mice. Biol Reprod. 2015;92(5):118."},{"issue":"3","key":"bib33","series-title":"Lab Anim.","first-page":"175","article-title":"Impact of anaesthetics and analgesics on fetal growth in the mouse","volume":"47","author":"Thaete LG","year":"2013","unstructured":"Thaete LG, Levin SI, Dudley AT. Impact of anaesthetics and analgesics on fetal growth in the mouse. Lab Anim. 2013;47(3):175\u2013183."},{"issue":"10","key":"bib34","series-title":"Lab Anim (NY).","first-page":"47","article-title":"A review of tribromoethanol anesthesia for production of genetically engineered mice and rats","volume":"34","author":"Meyer RE","year":"2005","unstructured":"Meyer RE, Fish RE. A review of tribromoethanol anesthesia for production of genetically engineered mice and rats. Lab Anim (NY). 2005;34(10):47\u201352."},{"issue":"2","key":"bib35","series-title":"Lab Anim Sci.","first-page":"189","article-title":"Efficacy of tribromoethanol anesthesia in mice","volume":"43","author":"Papaioannou VE","year":"1993","unstructured":"Papaioannou VE, Fox JG. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci. 1993;43(2):189\u2013192."},{"issue":"1","key":"bib36","series-title":"Sci Rep.","first-page":"12240","article-title":"Automated home-cage for the evaluation of innate non-reflexive pain behaviors in a mouse model of inflammatory pain","volume":"11","author":"Hasriadi","year":"2021","unstructured":"Hasriadi, Wasana PWD, Vajragupta O, Rojsitthisak P, Towiwat P. Automated home-cage for the evaluation of innate non-reflexive pain behaviors in a mouse model of inflammatory pain. Sci Rep. 2021;11(1):12240."},{"issue":"4","key":"bib37","series-title":"Lab Anim.","first-page":"304","article-title":"A comparison of abdominal and scrotal approach methods of vasectomy and the influence of analgesic treatment in laboratory mice","volume":"46","author":"Miller AL","year":"2012","unstructured":"Miller AL, Wright-Williams SL, Flecknell PA, Roughan JV. A comparison of abdominal and scrotal approach methods of vasectomy and the influence of analgesic treatment in laboratory mice. Lab Anim. 2012;46(4):304\u2013310."},{"issue":"5","key":"bib38","series-title":"J Am Assoc Lab Anim Sci.","first-page":"610","article-title":"Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad","volume":"49","author":"Adamson TW","year":"2010","unstructured":"Adamson TW, Kendall LV, Goss S, et al. Assessment of carprofen and buprenorphine on recovery of mice after surgical removal of the mammary fat pad. J Am Assoc Lab Anim Sci. 2010;49(5):610\u2013616."},{"issue":"4","key":"bib39","series-title":"Br J Pharmacol.","first-page":"547","article-title":"The animal pharmacology of buprenorphine, an oripavine analgesic agent","volume":"60","author":"Cowan A","year":"1977","unstructured":"Cowan A, Doxey JC, Harry EJ. The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol. 1977;60(4):547\u2013554."},{"issue":"1-2","key":"bib40","series-title":"ILAR J.","first-page":"238","article-title":"Mouse anesthesia: the art and science","volume":"62","author":"Navarro KL","year":"2021","unstructured":"Navarro KL, Huss M, Smith JC, Sharp P, Marx JO, Pacharinsak C. Mouse anesthesia: the art and science. ILAR J. 2021;62(1-2):238\u2013273."},{"issue":"4","key":"bib41","series-title":"Lab Anim Res.","first-page":"270","article-title":"Comparison of the anesthetic effects of 2,2,2-tribromoethanol on ICR mice derived from three different sources","volume":"34","author":"Lee MR","year":"2018","unstructured":"Lee MR, Suh HR, Kim MW, et al. Comparison of the anesthetic effects of 2,2,2-tribromoethanol on ICR mice derived from three different sources. Lab Anim Res. 2018;34(4):270\u2013278."},{"issue":"6 Pt 2","key":"bib42","series-title":"Am J Obstet Gynecol.","first-page":"735","article-title":"Metabolic effects of progesterone","volume":"142","author":"Kalkhoff RK","year":"1982","unstructured":"Kalkhoff RK. Metabolic effects of progesterone. Am J Obstet Gynecol. 1982;142(6 Pt 2):735\u2013738."},{"issue":"4","key":"bib43","series-title":"J Am Assoc Lab Anim Sci.","first-page":"368","article-title":"A simple and reliable method for early pregnancy detection in inbred mice","volume":"54","author":"Heyne GW","year":"2015","unstructured":"Heyne GW, Plisch EH, Melberg CG, Sandgren EP, Peter JA, Lipinski RJ. A simple and reliable method for early pregnancy detection in inbred mice. J Am Assoc Lab Anim Sci. 2015;54(4):368\u2013371."},{"issue":"7","key":"bib44","series-title":"Am J Vet Res.","first-page":"619","article-title":"Evaluation of an improved sustained-release buprenorphine formulation for use in mice","volume":"75","author":"Healy JR","year":"2014","unstructured":"Healy JR, Tonkin JL, Kamarec SR, et al. Evaluation of an improved sustained-release buprenorphine formulation for use in mice. Am J Vet Res. 2014;75(7):619\u2013625."},{"issue":"2","key":"bib45","series-title":"J Addict Med.","first-page":"242","article-title":"Skin necrosis following inadvertent dermal injection of extended-release buprenorphine","volume":"16","author":"Crouse E","year":"2022","unstructured":"Crouse E, Haught J, Tobarran N, Nichols C, Cumpston KL, Wills BK. Skin necrosis following inadvertent dermal injection of extended-release buprenorphine. J Addict Med. 2022;16(2):242\u2013245."},{"key":"bib46","series-title":"Adv Drug Deliv Rev.","first-page":"20","article-title":"Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction","volume":"127","author":"Chen W","year":"2018","unstructured":"Chen W, Yung BC, Qian Z, Chen X. Improving long-term subcutaneous drug delivery by regulating material-bioenvironment interaction. Adv Drug Deliv Rev. 2018;127:20\u201334."},{"issue":"7","key":"bib47","series-title":"J Pharm Sci.","first-page":"2072","article-title":"Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats","volume":"103","author":"Darville N","year":"2014","unstructured":"Darville N, van Heerden M, Vynckier A, et al. Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats. J Pharm Sci. 2014;103(7):2072\u20132087."},{"issue":"2","key":"bib48","series-title":"J Addict Med.","first-page":"227","article-title":"Subcutaneous extended-release buprenorphine depot misdiagnosed as an abscess resulting in incision and drainage and disruption of opioid use disorder treatment","volume":"17","author":"Gray JR","year":"2023","unstructured":"Gray JR, Kehoe LG, Peckham AM, Wakeman SE. Subcutaneous extended-release buprenorphine depot misdiagnosed as an abscess resulting in incision and drainage and disruption of opioid use disorder treatment. J Addict Med. 2023;17(2):227\u2013229."},{"key":"bib49","series-title":"Int J Mass Spectrom.","first-page":"92","article-title":"Intramuscular and subcutaneous drug depot characterization of a long-acting cabotegravir nanoformulation by MALDI IMS","volume":"437","author":"Groseclose MR","year":"2019","unstructured":"Groseclose MR, Castellino S. Intramuscular and subcutaneous drug depot characterization of a long-acting cabotegravir nanoformulation by MALDI IMS. Int J Mass Spectrom. 2019;437:92\u201398."},{"issue":"4","key":"bib50","series-title":"Curr Neuropharmacol.","first-page":"395","article-title":"Buprenorphine: a unique drug with complex pharmacology","volume":"2","author":"Lutfy K","year":"2004","unstructured":"Lutfy K, Cowan A. Buprenorphine: a unique drug with complex pharmacology. Curr Neuropharmacol. 2004;2(4):395\u2013402."},{"key":"bib51","series-title":"Neurotoxicology.","first-page":"292","article-title":"Perinatal morphine but not buprenorphine affects gestational and offspring neurobehavioral outcomes in mice","volume":"99","author":"Smith BL","year":"2023","unstructured":"Smith BL, Hassler A, Lloyd KR, Reyes TM. Perinatal morphine but not buprenorphine affects gestational and offspring neurobehavioral outcomes in mice. Neurotoxicology. 2023;99:292\u2013304."},{"issue":"7","key":"bib52","series-title":"J Neurosci.","first-page":"2538","article-title":"Developmental expression of the \u03bc, \u03ba, and \u03b4 opioid receptor mRNAs in mouse","volume":"18","author":"Zhu Y","year":"1998","unstructured":"Zhu Y, Hsu MS, Pintar JE. Developmental expression of the \u03bc, \u03ba, and \u03b4 opioid receptor mRNAs in mouse. J Neurosci. 1998;18(7):2538\u20132549."},{"issue":"4","key":"bib53","series-title":"J Am Assoc Lab Anim Sci.","first-page":"423","article-title":"The effects of perioperative analgesia on litter size in Crl:CD1(ICR) mice undergoing embryo transfer","volume":"49","author":"Goulding DR","year":"2010","unstructured":"Goulding DR, Myers PH, Goulding EH, Blankenship TL, Grant MF, Forsythe DB. The effects of perioperative analgesia on litter size in Crl:CD1(ICR) mice undergoing embryo transfer. J Am Assoc Lab Anim Sci. 2010;49(4):423\u2013426."},{"issue":"2","key":"bib54","series-title":"Lab Anim (NY).","first-page":"87","article-title":"The use of buprenorphine as an analgesic after rodent embryo transfer","volume":"37","author":"Krueger KL","year":"2008","unstructured":"Krueger KL, Fujiwara Y. The use of buprenorphine as an analgesic after rodent embryo transfer. Lab Anim (NY). 2008;37(2):87\u201390."}],"container-title":["Journal of the American Association for Laboratory Animal Science"],"original-title":[],"link":[{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/64\/4\/article-p696.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/64\/4\/article-p696.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aalas.kglmeridian.com\/downloadpdf\/journals\/72010024\/64\/4\/article-p696.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T00:32:05Z","timestamp":1756427525000},"score":1,"resource":{"primary":{"URL":"https:\/\/aalas.kglmeridian.com\/view\/journals\/72010024\/64\/4\/article-p696.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":54,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.30802\/aalas-jaalas-24-161","relation":{},"ISSN":["1559-6109"],"issn-type":[{"value":"1559-6109","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}